NVS : Summary for Novartis AG Common Stock - Yahoo Finance

U.S. Markets open in 7 hrs 42 mins

Novartis AG (NVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
77.45+0.60 (+0.78%)
At close: 4:02PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close76.85
Bid0.00 x
Ask0.00 x
Day's Range77.07 - 77.66
52 Week Range66.93 - 83.58
Avg. Volume3,364,424
Market Cap182.18B
PE Ratio (TTM)27.66
Earnings DateN/A
Dividend & Yield2.75 (3.57%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals15 hours ago

    Medford's Seventh Sense wins narrow FDA approval for blood-collection device

    Medford biotech Seventh Sense Biosystems said Thursday that the FDA has approved its push-button blood-collection device for use by healthcare professionals to monitor blood sugar. The move by the FDA allows Seventh Sense to market the device, called TAP, for monitoring blood sugar levels in diabetic and pre-diabetic patients. The privately-held, 25-employee company has billed TAP as the world's first push-button blood collection device.

  • MarketWatch18 hours ago

    5 reasons to invest in European stocks now

    Companies have had better earnings growth than those in the U.S. and valuations are low, among other factors.

  • Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
    Motley Fool3 days ago

    Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today

    The drugmaker announced a delay to approval of its three-times-weekly version of Glatopa.